94760 ⎘
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Sulfur atoms
ORGANIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC EQUIPMENT INCLUDING THE ELECTRONIC APPARATUS
#217-Beta-Hydroxysteroid Dehydrogenase Type 13 Inhibitors and Methods of Use Thereof
#3NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE IN CROP PROTECTION
#4MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#5INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#6INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#7PROCESS FOR THE PREPARATION OF DIVERSELY SUBSTITUTED CYANOCYCLOPROPYL-HETEROCYCLES OR ARENES
#8MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#9cGAS ANTAGONIST COMPOUNDS
#10NOVEL RHODANINE DERIVATIVES AND USES THEREOF
#11MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#12SULFINYLAMINOBENZAMIDE AND SULFONYLAMINOBENZAMIDE DERIVATIVES
#13SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME
#14COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
#15HETEROARYL-THIO-SUBSTITUTED PYRONES
#16cGAS antagonist compounds
#17PROTEIN AND LIPID THERAPEUTIC TARGETS
#18Compounds and compositions for treating conditions associated with NLRP activity
#19N-HETEROCYCLIC COMPOUNDS USED AS NITRIFICATION INHIBITOR
#20Cathode active material for lithium secondary battery and method of manufacturing the same
#21INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF
#22DIMETHYLSULFOXIMINE DERIVATIVE
#23Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#24COMPOUND AS A UBR BOX DOMAIN LIGAND
#25COMPOUND AS A UBR BOX DOMAIN LIGAND
#2617-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS OF USE THEREOF
#27Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith
#28PYRROLIDINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BETA-AMYLOID OR TAU PROTEIN-ASSOCIATED DISEASES CONTAINING SAME
#29Compounds and compositions for treating conditions associated with NLRP activity
#30COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
#31Compounds and compositions for treating conditions associated with NLRP activity
#32COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
#33METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY
#34Amide derivative and preparation method therefore and use thereof in medicine
#35COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
#36ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#37Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer
#38CGAS antagonist compounds
#392-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof
#40NLRP MODULATORS
#41PROCESS FOR THE PREPARATION OF FLUENSULFONE
#42SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF
#43Heteroaryl-thio-substituted pyrones
#44Sulfonylureas and related compounds and use of same
#45MYC-MAX INHIBITOR COMPOUND THERAPEUTICS FOR CANCER TREATMENT, METHODS AND USES ASSOCIATED THEREWITH
#46NLRP3 INHIBITORS
#47Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives
#482-THIOXOTHIAZOLIDIN-4-ONE DERIVATIVES ACTIVE AS TRANSTHYRETIN LIGANDS AND USES THEREOF
#49Process and intermediates for the preparation of Fluensulfone
#50Cathode active material for lithium secondary battery and method of manufacturing the same
#51NLRP MODULATORS
#52Synthesis of 1,1,2-trifluoro-4-(substituted sufonyl)-but-1-ene
#53Compounds and compositions for treating conditions associated with NLRP activity
#54Small molecule inhibitors of fungal hyphae and biofilm formation
#55Compounds and compositions for treating conditions associated with NLRP activity
#56Synthesis of 5-chloro-2-[(3,4,4-trifluoro-3-buten-1-yl)THIO]-thiazole
#57Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer
#58FLUORALKENYL COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF
#59Androgen receptor modulators and methods for their use
#60Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#61Cathode active material for lithium secondary battery and method of manufacturing the same
#62FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
#63Membrane-impermeant fluorogenic chromophores
#64HETEROCYCLIC INTEGRIN AGONISTS
#65ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#66Compounds and compositions for treating conditions associated with NLRP activity
#67THIAZOLE COMPOUND AND HERBICIDE
#68Imidazole and thiazole compositions for modifying biological signaling
#69Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives
#70Sulfonylureas and related compounds and use of same
#71Deoxyuridine triphosphatase inhibitors
#72Rational drug design targeting resistant gram-negative bacterial infections to polymyxin-class antibiotics
#73Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer
#74Compounds and compositions for treating conditions associated with NLRP activity
#75Compounds and compositions for treating conditions associated with NLRP activity
#76Compounds and compositions for treating conditions associated with NLRP activity
#77USE OF HETEROCYCLIC FLUOROALKENYL SULFONE COMPOUNDS FOR REPELLING MOLLUSCS
#782-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof
#79Redox-activated pro-chelators
#80Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#81Thiazolidinedione derivative and use thereof
#82In Vivo Methods for Enhancing Bioenergetic Status in Female Germ Cells
#83Imidazole and thiazole compositions for modifying biological signaling
#84cGAS antagonist compounds
#85Deoxyuridine triphosphatase inhibitors
#86Compositions and Methods for Enhancing Bioenergetic Status in Female Germ Cells
#87Inhibitors of the Notch transcriptional activation complex and methods for use of the same
#88Sulfonylureas and related compounds and use of same
#89Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#90Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#91Beta lactamase inhibitors
#92Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#93USE OF HETEROCYCLIC FLUOROALKENYL SULFONE COMPOUNDS FOR REPELLING MOLLUSCS
#94Imidazole and thiazole compositions for modifying biological signaling
#95Prevention and treatment of non-alcoholic fatty liver disease
#96DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
#97Choline cocrystal of epalrestat
#98Vinylogous thioester compounds and methods of use
#99Fluorogen activating and shifting tag (FAST)
#100Sulfonyl hydrazide compounds and a regio-selective process to prepare 4-aroyl pyrazole derivatives
#101Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin
#102Thiazole compound and its use in pest control
#103Compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor
#104Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#105Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#106Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#107Organic dyes comprising a hydrazone moiety and their use in dye-sensitized solar cells
#108Fullerene derivative, organic solar cell using same, and manufacturing method thereof
#109Deoxyuridine triphosphatase inhibitors
#110Agent for the prophylaxis and/or treatment of neoplastic diseases
#111Compositions and Methods for Enhancing Bioenergetic Status in Female Germ Cells
#112Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases
#113Potassium channel blockers
#114Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
#115Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ]
#116Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method
#117Choline cocrystal of epalrestat
#118NOVEL SULFONATE-BASED TRIMEBUTINE SALTS
#119DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
#120Color-forming composition, color-forming curable composition, lithographic printing plate precursor and plate making method, and color-forming compound
#121Compounds for modulating integrin CD11B/CD18
#122Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#123METHOD FOR PRODUCING ALPHA-HYDROXY KETONE COMPOUND
#124Agents and methods for treating ischemic and other diseases
#125Cyclohexanone compounds and herbicides comprising the same
#126Solid forms of epalrestat
#127Potassium channel blockers
#128Thioxothiazolidine derivative having Ras function inhibitory effect
#129Apoptosis promoters
#130Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
#131Rubber composition including a thiazole derivative
#132Flavivirus inhibitors and methods of their use
#133Efficient production of heterologous proteins using mannosyl transferase inhibitors
#134Substituted N-(2-arylamino)aryl sulfonamide-containing combinations
#1354-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists
#136Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#137Rubber Composition Comprising a Thiazole
#138Compositions and methods for enhancing bioenergetic status in female germ cells
#139Compounds for modulating integrin CD11b/CD18
#140Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
#141COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF
#142UREA SUBSTITUTED SULPHONAMIDE DERIVATIVES
#143CYCLOPROPANE DERIVATIVES
#144SORTASE A INHIBITORS
#145Compounds, Compositions and Methods for Modulating Uric Acid Levels
#146Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#147CATHEPSIN CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF VARIOUS DISEASES
#148Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
#149LPA RECEPTOR ANTAGONIST
#150Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
#151Iminopropene compound and use thereof
#152Cysteine protease inhibitors
#153Acetanilide sphingosine-1-phosphate receptor antagonists
#154Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors
#155Choline cocrystal of epalrestat
#156Solid forms of epalrestat
#157Thiazolidinedione derivative and use thereof
#158Apoptosis promoters
#159Agents and methods for treating ischemic and other diseases
#160Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
#161LABELING COMPOSITION FOR INTRAOCULAR TISSUE, LABELING METHOD OF INTRAOCULAR TISSUE, AND SCREENING METHOD
#162inhibitors and methods for their use
#163Sulfonamide compounds or salts thereof
#164HIV-1 Protease Inhibitors
#165Apoptosis promoters
#166Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#167IDO INHIBITORS AND THERAPEUTIC USES THEREOF
#168Modulators of protein kinase signaling
#169WATER SOLUBLE SMALL MOLECULE INHIBITORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#170Efficient production of heterologous proteins using mannosyl transferase inhibitors
#171IDO inhibitors
#172Treating and preventing viral infections
#173Chiral 2-(benzylsulfinyl)thiazole derivatives and 2-[(1H-pyrazol-4-ylmethyl)sulfinyl]thiazole derivatives, processes for their preparation and their use as herbicides and plant growth regulators
#174THIAZOLYLOXYPHENYLAMIDINES OR THIADIAZOLYLOXYPHENYLAMIDINES AND THEIR USE AS FUNGICIDES
#175Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#176LPA receptor antagonist
#177Sulfonyl-substituted 6-membered ring derivative
#178Apoptosis promoters
#179Imidate compound and use thereof for pest control
#180NOVEL SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE
#181Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#182Novel Pharmaceutical Compounds
#183Cyclohexyl sulfonamide derivatives
#184Cyclopropane compounds and pharmaceutical use thereof
#185Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#186Potassium channel blockers
#187Potassium channel blockers
#188Therapeutic agent for urinary excretion disorder
#189Compounds for modulating integrin CD11b/CD18
#190N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
#191BIARYL SULFONAMIDE DERIVATIVES
#192Apoptosis promoters
#193Heteroaryl-substituted carboxamides and their use as pharmaceuticals
#194NON-IMIDAZOLE ARYLOXYALKYLAMINES
#195Sulfonamide compound or salt thereof
#196Substituted amides
#197Antimicrobial agents
#198Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses
#199Preparation of thiazoles
#200Benzylthiazolone inhibitors of estrogen-related receptors (ERR)
#201COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS
#202Benzoic Acid Derivatives that are Modulators or Agonists of GlyR
#203Inhibitors of histone deacetylase
#2045-Membered heterocyclic compound
#205Nitrogenated aromatic compound, process for production of the same, polymer, and proton conductive membrane
#206Non-nucleoside reverse transcriptase inhibitors
#207INHIBITORS OF ANTI-APOPTOTIC PROTEINS
#208Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors
#209Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#210Novel MAO-A inhibitors
#211Novel Herbicides
#212Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor
#213Receptor function regulator
#214Cyclopropane compounds and pharmaceutical use thereof
#215NON-IMIDAZOLE ARYLOXYALKYLAMINES
#216LPA receptor antagonist
#217Novel sulfonamide inhibitors of aspartyl protease
#218Molecules for regulating cell death
#219Hydroquinone derivative skin brightening compounds
#220Arylsulfones and uses related thereto
#221CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#222PPAR active compounds
#223Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
#224Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
#225Substituted pyridyoxy amides
#226Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
#227Inhibitors of histone deacetylase
#228Inhibitors of histone deacetylase
#229Thioxothiazolidinone Compounds For Use As Pharmaceuticals
#230Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#231Preparation of thiazoles
#232Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#233New Compounds 317
#234Enzyme inhibitors
#235Iminopropene compound and use thereof
#236Hydroxy Alkyl Amines
#237BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
#238Compounds to treat Alzheimer's disease
#239N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
#240Modulation of Pathogenicity
#241ABCA1 elevating compounds
#242Low molecular weight Myc-max inhibitors
#243Compounds And Compositions As Ppar Modulators
#244Modulation of Pathogenicity
#245CALCIUM CHANNEL ANTAGONISTS
#246Modulation of Pathogenicity
#247Modulation of Pathogenicity
#248Modulation of Pathogenicity
#249Cyclohexyl sulfonamide derivatives
#250Potassium channel modulators
#251Antibacterial compounds
#252Modulation of Pathogenicity
#253Apoptosis promoters
#254Preparation of thiazoles
#255Nitric oxide donors and uses thereof
#256Apoptosis promoters
#257Acylaminothiazole derivatives and use thereof as β-amyloid inhibitors
#258Apoptosis promoters
#259Heterocyclic diphenyl ethers
#260Non-imidazole aryloxyalkylamines
#261Thiophene-and thiazolesulfonamides as antineoplastic agents
#262Sulfonamide derivatives as PPAR modulators
#263Cyclopropane compounds and pharmaceutical use thereof
#264Sulfonamide inhibitors of aspartyl protease
#265Method for producing halogenated 2-(3-butenylsulphanyl)-1,3-thiazoles
#266Method for producing halogenated 2-(3-butenylsulphanyl)-1,3-thiazoles
#267Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof
#268Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
#269LPA receptor antagonist
#270Hexafluoroisopropanol substituted cyclohexane derivatives
#271Apoptosis promoters
#2727-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
#273Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#274Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof
#275Process for ezetimibe intermediate
#276N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
#277Sulfonamides as inhibitors of histone deacetylase for the treatment of disease
#278Pesticidal fluoroalkene derivatives
#279Method for producing heterocyclic fluoroalkenyl sulfones
#280Inhibitors of HCV NS5B polymerase
#281Substituted heterocycles for the treatment of diabetes and other diseases
#282Diphenyl ether derivatives
#283Non nucleoside reverse transcriptase inhibitors
#284Arylsulfones and uses related thereto
#2853-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides
#286Sulphones for inhibition of gamma secretase
#287Alpha-sulfonylamino-acetonitriles
#288β-amyloid protein production/secretion inhibitor
#289Substituted amides
#290Non-imidazole aryloxypiperidines
#291Bisarylsulfonamide compounds and their use in cancer therapy
#292Process for the preparation of thioalkylamine derivatives
#293N-acylsulfonamide apoptosis promoters
#294Antibacterial compounds
#295Method for producing halogenated 2-(3-butenylsulphanyl)-1,3-thiazoles
#296N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
#297Imidazolidinedione derivatives for the treatment of diabetes and other diseases
#298Novel molecules for regulating cell death
#299Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
#300Enzyme inhibitors